ProCE Banner Activity

How I Follow People With CHB Who Are Not on Treatment

Clinical Thought

Criteria to treat people with CHB vary by guideline, so it is important to evaluate treatment eligibility on a case-by-case basis and perform close monitoring. Read my commentary to learn my approach to monitoring people who are not receiving antiviral therapy.

Released: April 15, 2024

Expiration: April 14, 2025

Share

Faculty

Robert S. Brown, Jr.

Robert S. Brown, Jr., MD, MPH

Vincent Astor Distinguished Professor of Medicine
Chief, Division of Gastroenterology and Hepatology
Weill Cornell Medicine
New York, New York

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

Disclosure

Primary Author

Robert S. Brown, Jr., MD, MPH

Vincent Astor Distinguished Professor of Medicine
Chief, Division of Gastroenterology and Hepatology
Weill Cornell Medicine
New York, New York

Robert S. Brown, Jr., MD, MPH: consultant/advisor/speaker: AbbVie, Gilead, Intercept, Mallinckrodt, Mirum.